AffiliationTallaght Breast Unit, Adelaide and Meath Hospital Tallaght, Dublin, Ireland.
MetadataShow full item record
CitationBreast J. 2009 Sep-Oct;15 Suppl 1:S33-8.
JournalThe breast journal
AbstractBreast cancer is the most common cancer affecting European women and the leading cause of cancer-related death. A total of 15-20% of women who develop breast cancer have a family history and 5-10% a true genetic predisposition. The identification and screening of women at increased risk may allow early detection of breast cancer and improve prognosis. We established a family risk assessment clinic in May 2005 to assess and counsel women with a family history of breast cancer, to initiate surveillance, and to offer risk-reducing strategies for selected high-risk patients. Patients at medium or high risk of developing breast cancer according to NICE guidelines were accepted. Family history was determined by structured questionnaire and interview. Lifetime risk of developing breast cancer was calculated using Claus and Tyrer-Cuzick scoring. Risk of carrying a breast cancer-related gene mutation was calculated using the Manchester system. One thousand two hundred and forty-three patients have been referred. Ninety-two percent were at medium or high risk of developing breast cancer. Formal assessment of risk has been performed in 368 patients, 73% have a high lifetime risk of developing breast cancer, and 72% a Manchester score >or=16. BRCA1/2 mutations have been identified in 14 patients and breast cancer diagnosed in two. Our initial experience of family risk assessment has shown there to be a significant demand for this service. Identification of patients at increased risk of developing breast cancer allows us to provide individuals with accurate risk profiles, and enables patients to make informed choices regarding their follow-up and management.
- Screening and follow-up of the patient at high risk for breast cancer.
- Authors: Willey SC, Cocilovo C
- Issue date: 2007 Dec
- Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.
- Authors: Fasching PA, Bani MR, Nestle-Krämling C, Goecke TO, Niederacher D, Beckmann MW, Lux MP
- Issue date: 2007 Jun
- Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.
- Authors: Hoskins KF, Zwaagstra A, Ranz M
- Issue date: 2006 Oct 15
- MRI screening in a clinic population with a family history of breast cancer.
- Authors: Yu J, Park A, Morris E, Liberman L, Borgen PI, King TA
- Issue date: 2008 Feb
- Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.
- Authors: Loescher LJ, Lim KH, Leitner O, Ray J, D'Souza J, Armstrong CM
- Issue date: 2009 Mar